Safety of postoperative administration of human urinary trypsin inhibitor in lung cancer patients with idiopathic pulmonary fibrosis

PLoS ONE

Volumn 6, Issue 12, 2011, Pages

  Yamauchi, Yoshikane ^a   Izumi, Yotaro ^a   Inoue, Masanori ^a   Sugiura, Hiroaki ^a   Goto, Taichiro ^a   Anraku, Masaki ^a   Ohtsuka, Takashi ^a   Kohno, Mitsutomo ^a   Soejima, Kenzo ^a   Nomori, Hiroaki ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ULINASTATIN; GLYCOPROTEIN;

ABDOMINAL DISEASE; ADULT; AGED; ARTICLE; CANCER PATIENT; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG DOSE ESCALATION; DRUG EFFECT; DRUG ERUPTION; DRUG MEGADOSE; DRUG SAFETY; FEASIBILITY STUDY; FEMALE; FIBROSING ALVEOLITIS; HUMAN; KIDNEY DYSFUNCTION; LIVER DYSFUNCTION; LUNG CANCER; LUNG RESECTION; MALE; POSTOPERATIVE CARE; UNSPECIFIED SIDE EFFECT; LUNG TUMOR; MIDDLE AGED; POSTOPERATIVE PERIOD;

ADULT; AGED; AGED, 80 AND OVER; GLYCOPROTEINS; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; LUNG NEOPLASMS; MALE; MIDDLE AGED; POSTOPERATIVE PERIOD;

EID: 84055172763     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0029053     Document Type: Article

References (29)

1. Hubbard R, Venn A, Lewis S, Britton J, (2000) Lung cancer and cryptogenic fibrosing alveolitis. A population-based cohort study. Am J Respir Crit Care Med 161: 5-8.
2. Le Jeune I, Gribbin J, West J, Smith C, Cullinan P, et al. (2007) The incidence of cancer in patients with idiopathic pulmonary fibrosis and sarcoidosis in the UK. Respir Med 101: 2534-2540.
3. Samet JM, (2000) Does idiopathic pulmonary fibrosis increase lung cancer risk? Am J Respir Crit Care Med 161: 1-2.
4. Miyamoto A, Kishi K, Yoshimura K, (2011) [A nationwide survey concerning lung surgery for lung cancer associated with idiopathic interstitial pneumonia]. Nihon Kokyuki Gakkai Zasshi 49: 148-150.
5. Ohnishi H, Suzuki K, Niho T, Ito C, Yamaguchi K, (1985) Protective effects of urinary trypsin inhibitor in experimental shock. Jpn J Pharmacol 39: 137-144.
6. Ohnishi H, Kosuzume H, Ashida Y, Kato K, Honjo I, (1984) Effects of urinary trypsin inhibitor on pancreatic enzymes and experimental acute pancreatitis. Dig Dis Sci 29: 26-32.
7. Endo S, Inada K, Taki K, Hoshi S, Yoshida M, (1990) Inhibitory effects of ulinastatin on the production of cytokines: implications for the prevention of septicemic shock. Clin Ther 12: 323-326.
8. Cai M, Ogawa R, (1994) Effects of free radical scavengers, methylprednisolone, and ulinastatin on acute xanthine and xanthine oxidase-induced lung injury in rats. Circ Shock 43: 71-78.
9. Kawamura T, Inada K, Akasaka N, Wakusawa R, (1996) Ulinastatin reduces elevation of cytokines and soluble adhesion molecules during cardiac surgery. Can J Anaesth 43: 456-460.
10. Katoh H, Ishikawa H, Hasegawa M, Yoshida Y, Suzuki Y, et al. (2010) Protective effect of urinary trypsin inhibitor on the development of radiation-induced lung fibrosis in mice. J Radiat Res (Tokyo) 51: 325-332.
11. Bao P, Gao W, Li S, Zhang L, Qu S, et al. (2009) Effect of pretreatment with high-dose ulinastatin in preventing radiation-induced pulmonary injury in rats. Eur J Pharmacol 603: 114-119.
12. Kondo D, Imaizumi M, Abe T, (1993) [Study on extravascular lung water and polymorphonuclear leukocyte elastase during acute phase following radical treatment of lung cancer: effect of ulinastatin on respiratory functions]. Kyobu Geka 46: 922-925.
13. Sensaki K, Masuda H, Kikuchi K, Takagi K, Kase K, et al. (1993) Postoperative immunity in lung cancer patients and the effect of granulocyte protease inhibitor (ulinastatin). Jpn J Lung Cancer 33: 61-69.
14. Tsujimura S, Saito K, Nakayamada S, Tanaka Y, (2005) Human urinary trypsin inhibitor bolus infusion improved severe interstitial pneumonia in mixed connective tissue disease. Mod Rheumatol 15: 374-380.
15. Tsujimura S, Saito K, Nakayamada S, Tanaka Y, (2008) Bolus infusion of human urinary trypsin inhibitor improves intractable interstitial pneumonia in patients with connective tissue diseases. Rheumatology (Oxford) 47: 907-913.
16. The Japanese Respiratory Society (2004) Idiopathic Intestitial Pneumonias: Diagnosis and Treatment Tokyo Nankodo.
17. The Japan Lung Cancer Society (2010) General rules for clinical and pathologic recording of lung cancer. 7th.ed Tokyo Kimbara.
18. Collard HR, Moore BB, Flaherty KR, Brown KK, Kaner RJ, et al. (2007) Acute exacerbations of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 176: 636-643.
19. Hoshikawa Y, Kondo T, (2004) [Perioperative lung injury: acute exacerbation of idiopathic pulmonary fibrosis and acute interstitial pneumonia after pulmonary resection]. Nippon Geka Gakkai Zasshi 105: 757-762.
20. Minegishi Y, Sudoh J, Kuribayasi H, Mizutani H, Seike M, et al. (2011) The safety and efficacy of weekly paclitaxel in combination with carboplatin for advanced non-small cell lung cancer with idiopathic interstitial pneumonias. Lung Cancer 71: 70-74.
21. Hanibuchi M, Yamaguchi T, Okada T, Nakagawa M, Yokota S, et al. (2001) Clinical examination of acute exacerbation of idiopathic intestitial Pneumonia (IIP) combined with lung cancer after anti-cancer treatment. Jpn J Lung Cancer 41: 281-286.
22. Takenaka K, Yoshimura A, Okano T, Seike M, Kamio K, et al. (1999) Acute Exacerbation of idiopathic interstitial pneumonia complicated by lung cancer, caused by treatment for lung cancer. Jpn J Lung Cancer 39: 955-962.
23. Takeda A, Enomoto T, Sanuki N, Nakajima T, Takeda T, et al. (2008) Acute exacerbation of subclinical idiopathic pulmonary fibrosis triggered by hypofractionated stereotactic body radiotherapy in a patient with primary lung cancer and slightly focal honeycombing. Radiat Med 26: 504-507.
24. Fujimoto T, Okazaki T, Matsukura T, Hanawa T, Yamashita N, et al. (2003) Operation for lung cancer in patients with idiopathic pulmonary fibrosis: surgical contraindication? Ann Thorac Surg 76: 1674-1678; discussion 1679.
25. Kumar P, Goldstraw P, Yamada K, Nicholson AG, Wells AU, et al. (2003) Pulmonary fibrosis and lung cancer: risk and benefit analysis of pulmonary resection. J Thorac Cardiovasc Surg 125: 1321-1327.
26. Watanabe A, Higami T, Ohori S, Koyanagi T, Nakashima S, et al. (2008) Is lung cancer resection indicated in patients with idiopathic pulmonary fibrosis? J Thorac Cardiovasc Surg 136: 1357-1363, 1363 e1351-1352.
27. Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, et al. (2011) An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management. Am J Respir Crit Care Med 183: 788-824.
28. Ebina M, Taniguchi H, Miyasho T, Yamada S, Shibata N, et al. (2011) Gradual increase of high mobility group protein b1 in the lungs after the onset of acute exacerbation of idiopathic pulmonary fibrosis. Pulm Med 2011: 916486.
29. Willis BC, Liebler JM, Luby-Phelps K, Nicholson AG, Crandall ED, et al. (2005) Induction of epithelial-mesenchymal transition in alveolar epithelial cells by transforming growth factor-beta1: potential role in idiopathic pulmonary fibrosis. Am J Pathol 166: 1321-1332.